Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Gynecology & Obstetrics
Cover of the book Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642281600
Publisher: Springer Berlin Heidelberg Publication: April 23, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642281600
Publisher: Springer Berlin Heidelberg
Publication: April 23, 2012
Imprint: Springer
Language: English

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

More books from Springer Berlin Heidelberg

Cover of the book Optical Properties of Nanostructured Metallic Systems by
Cover of the book Off-Diagonal Bethe Ansatz for Exactly Solvable Models by
Cover of the book Industrial Project Management by
Cover of the book Wie das Leben zum Urlaub wird by
Cover of the book Regulation of Sexual Conduct in UN Peacekeeping Operations by
Cover of the book General Trauma Care and Related Aspects by
Cover of the book Universities and Climate Change by
Cover of the book Pearls of Glaucoma Management by
Cover of the book Female Contraception by
Cover of the book Stochastic Models in Life Insurance by
Cover of the book Air Pollution by
Cover of the book Online-Marketing für das erfolgreiche Krankenhaus by
Cover of the book Mikroskopischer Farbatlas pflanzlicher Drogen by
Cover of the book Globalization of Professional Services by
Cover of the book Aussage gegen Aussage in sexuellen Missbrauchsverfahren by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy